Comparative Analysis of Dry Market Sample of Acorus calamus Linn. Sample with Pharmacopoeial Standards

A comparative analysis of market-available dry Acorus calamus Rhizome samples with pharmacopoeial standards provides valuable insights into the quality and authenticity of these products. The study revealed significant variations in morphological features among the market samples, highlighting the need for stringent quality control measures. The sample was identified as Acorus calamus Linn. While the drug meets API standards, it lacks a few features. Most of the samples are of irregular shape rather than cylindrical, and triangular, transverse leaf scars were absent. These observations suggest potential variations or discrepancies in the market-available samples compared to pharmacopoeial standards. Further investigations and quality control measures are essential to ensure the consistency and efficacy of Acorus calamus products in traditional and modern medicinal practices.